Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor

Last updated: March 15, 2023
Sponsor: Guangdong Provincial People's Hospital
Overall Status: Trial Not Available

Phase

N/A

Condition

Lung Cancer

Pneumonia

Non-small Cell Lung Cancer

Treatment

N/A

Clinical Study ID

NCT04894682
KY-Q-2021-087-01
  • Ages 18-85
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The objective of this study is to assess the inoculation-related symptoms and long-term effects of COVID-19 vaccines in patients with lung cancer or pulmonary nodules in a real-world setting. The investigators aim to provide high-quality evidence for the COVID-19 vaccines in cancer/pre-cancer patients, and to address their concern about the safety profile of the newly developed vaccines.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Pulmonary nodule/lung cancer patients confirmed by CT or pathological examination, whohave been vaccinated against the SARS-CoV-2
  2. Pulmonary nodule/lung cancer patients confirmed by CT or pathological examination, whoare not vaccinated against the SARS-CoV-2
  3. Healthy people who have been vaccinated against the SARS-CoV-2

Exclusion

Exclusion Criteria:

  1. Multiple malignancy in other parts of body;
  2. Infected with SARS-CoV-2 virus currently or in the past;
  3. Refuse to participate in this study.

Study Design

Study Start date:
May 04, 2021
Estimated Completion Date:
May 31, 2022

Study Description

This study will enroll lung cancer/pulmonary nodule patients or healthy people who had undergone standard vaccination procedures against SARS-CoV-2/COVID-19. This observatory study will apply an electronic questionnaire to collect general information and post-vaccination symptoms or adverse events of vaccinated pulmonary nodules/lung cancer patients and healthy control. The researchers will further analyze whether the vaccine will promote the progression of primary tumors/pulmonary nodules through long-term follow-up. The investigators aim to assess the adverse events and long-term impact of COVID-19 vaccines in patients with lung cancer or pulmonary nodules in a real-world setting, to provide high-quality evidence for the COVID-19 vaccines in cancer/pre-cancer patients, and to address their concern about the safety profile of the newly developed vaccines.

Connect with a study center

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong 510080
    China

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.